Impaired production of T-lymphocyte mitogens in pediatric malignant disease

Burnet, 1970, Progr. Exp. Tumor Res., 12, 1, 10.1159/000386035 Hellstrom, 1974, Advan. Immunol., 18, 209, 10.1016/S0065-2776(08)60311-9 Kersey, 1975, 55 Eltringham, 1973, Na. Cancer Inst. Monogr., 36, 107 Dupuy, 1971, Cancer, 27, 323, 10.1002/1097-0142(197102)27:2<323::AID-CNCR2820270212>3.0.CO;2-M Catalona, 1972, Clin. Exp. Immunol., 12, 325 Catalona, 1973, Cancer, 31, 65, 10.1002/1097-0142(197301)31:1<65::AID-CNCR2820310109>3.0.CO;2-Y Rocklin, R., In “Progress in Clinical Immunology” (R. S. Schwartz, Ed.), p. 21. Grune and Stratton, New York. Wybran, 1973, J. Clin. Invest., 52, 1026, 10.1172/JCI107267 Gross, 1975, N. Engl. J. Med., 292, 439, 10.1056/NEJM197502272920901 Gery, 1972, J. Exp. Med., 136, 143, 10.1084/jem.136.1.143 Erb, 1975, Cell. Immunol., 19, 366, 10.1016/0008-8749(75)90217-8 Meltzer, 1977, J. Immunol., 118, 77, 10.4049/jimmunol.118.1.77 Chen, 1976, Cell. Immunol., 22, 211, 10.1016/0008-8749(76)90024-1 Boyum, 1968, Scand. J. Clin. Invest., 21 Julius, 1973, J. Immunol., 3, 645 Altman, 1961 Mizel, 1977, 36, 1300 Chung, 1977, J. Pediatr., 90, 548, 10.1016/S0022-3476(77)80364-8 Esber, 1976, Amer. J. Hematol., 1, 211, 10.1002/ajh.2830010205